Core Laboratories Inc. (CLB)

Core Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	575	746	813	825	940	1,033
Market Cap Growth	-1.21%	-8.16%	-1.51%	-12.21%	-8.98%	-12.45%
Enterprise Value	717	894	992	1,042	1,167	1,277
Last Close Price	12.53	15.99	17.22	17.53	20.08	22.06

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	24.07	25.16	25.88	22.50	48.32	52.35
Forward PE	19.89	21.66	18.55	17.98	23.39	24.73
PS Ratio	1.11	1.42	1.55	1.62	1.92	2.20
PB Ratio	2.11	2.74	3.22	3.59	4.97	6.41
P/TBV Ratio	3.59	4.88	5.78	6.97	12.16	21.13
P/FCF Ratio	52.84	33.26	18.74	58.07	63.77	44.82
P/OCF Ratio	20.37	20.16	14.41	33.29	37.66	28.23
PEG Ratio	2.22	14.84	0.99	0.36	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	1.38	1.70	1.89	2.04	2.38	2.72
EV/EBITDA Ratio	12.56	13.47	14.79	14.32	19.38	21.36
EV/EBIT Ratio	16.97	17.28	19.04	18.29	27.11	30.93
EV/FCF Ratio	65.92	39.83	22.88	73.32	79.18	55.45

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.59	0.60	0.71	0.94	1.18	1.59
Debt / EBITDA Ratio	2.12	1.89	2.06	2.30	2.78	3.18
Debt / FCF Ratio	15.18	7.31	4.16	15.16	15.09	11.10
Net Debt / Equity Ratio	0.51	0.52	0.64	0.87	1.10	1.48
Net Debt / EBITDA Ratio	2.49	2.13	2.40	2.75	3.44	3.98
Net Debt / FCF Ratio	13.09	6.30	3.71	14.09	14.04	10.33
Asset Turnover	0.87	0.90	0.89	0.88	0.85	0.82
Inventory Turnover	7.10	7.33	6.42	6.05	7.44	8.80
Quick Ratio	1.37	1.35	1.38	1.57	1.27	1.37
Current Ratio	2.12	2.03	2.16	2.53	2.05	2.08
Return on Equity (ROE)	9.05%	11.59%	13.34%	17.68%	11.24%	17.09%
Return on Assets (ROA)	4.45%	5.53%	5.56%	6.11%	4.64%	4.49%
Return on Invested Capital (ROIC)	6.74%	8.28%	8.60%	12.39%	7.11%	5.85%
Return on Capital Employed (ROCE)	8.70%	10.80%	10.80%	11.40%	9.10%	8.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	4.24%	3.98%	3.86%	4.45%	2.07%	1.91%
FCF Yield	1.89%	3.01%	5.33%	1.72%	1.57%	2.23%
Dividend Yield	0.32%	0.25%	0.23%	0.23%	0.20%	0.18%
Payout Ratio	7.68%	6.30%	5.97%	5.09%	9.53%	9.30%
Buyback Yield / Dilution	1.80%	1.38%	-0.34%	-1.52%	-0.26%	-4.98%
Total Shareholder Return	2.12%	1.63%	-0.11%	-1.29%	-0.06%	-4.79%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error